COVID-19-associated rhabdomyolysis in a paediatric patient with sickle cell trait.

J Paediatr Child Health

Department of Nephrology, Children's Hospital Westmead, Sydney, New South Wales, Australia.

Published: September 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpc.15867DOI Listing

Publication Analysis

Top Keywords

covid-19-associated rhabdomyolysis
4
rhabdomyolysis paediatric
4
paediatric patient
4
patient sickle
4
sickle cell
4
cell trait
4
covid-19-associated
1
paediatric
1
patient
1
sickle
1

Similar Publications

COVID-19-associated rhabdomyolysis: A scoping review.

Int J Infect Dis

November 2023

Department of Medicine, University of California, San Diego. Electronic address:

Objectives: SARS-CoV-2 infection ("COVID-19") and the hypoxemia that has attended some cases may predispose to rhabdomyolysis. We sought to identify reported cases of COVID-19-associated rhabdomyolysis, examining concurrent risk factors (RFs) and mortality outcomes.

Methods: We searched PubMed for articles conveying individual-level information on COVID-19-associated rhabdomyolysis, published between January 2020 and July 2022, with an English-language abstract.

View Article and Find Full Text PDF

Rhabdomyolysis is a condition characterized by the destruction of skeletal muscle cells with the release of myoglobin and creatine kinase into the blood. Viral infections such as influenza and Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) have been associated with rhabdomyolysis with varying degrees of morbidity and mortality. We present the case of a male in his early thirties who was diagnosed with rhabdomyolysis associated with coronavirus disease 2019 (COVID-19) infection who developed excessively high creatine kinase levels, peaking at 1,650,000 U/L.

View Article and Find Full Text PDF

A 50 year old patient presented with bilateral lower extremity weakness, lethargy, and dyspnea. Nasopharyngeal swab was positive for SARS-CoV-2. She progressed to acute hypoxemic respiratory failure and hemodynamic instability requiring intubation, pressor support, and hemodialysis.

View Article and Find Full Text PDF

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. Although coronavirus disease-19 (COVID-19) affects every population group, the sports community and athletes require special consideration of the effects on cardiovascular, musculoskeletal, neurologic, and respiratory systems. A comprehensive understanding of imaging indications, findings, and features of COVID-19 supports appropriate imaging utilization and effective patient management and treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!